Kommentar zum 2016 Positionspapier der Europäischen Gesellschaft für Kardiologie (ESC) zu kardiovaskulären Komplikationen onkologischer Therapien

Pfister R, Achenbach S, Boenner F, Mueller OJ, Hallek M, Kochanek M, Bokemeyer C, Weissinger F, Lueftner D, Baldus S, Kelm M (2018)

Publication Type: Journal article, Review article

Publication year: 2018

Journal

Der Kardiologe Springer Verlag

Book Volume: 12

Pages Range: 19-25

Journal Issue: 1

DOI: 10.1007/s12181-017-0209-2

Abstract

Resulting from advances in oncological treatment, cancer patients frequently experience cardiovascular complications of the cancer treatment. Furthermore, many of the recently developed new drugs in oncology are potentially associated with cardiovascular side effects. Given this increased complexity in the field of cardio-oncology, the European Society of Cardiology published a position paper on cancer treatment and cardiovascular toxicity in August 2016. This position paper for the first time systematically reviewed the pathophysiology and clinical manifestations of cardiovascular disease entities during and after cancer treatment and provided suggestions for screening, diagnosis, monitoring, prevention and treatment. The following comments of the German Society of Cardiology in cooperation with the German Society of Hematology and Medical Oncology briefly summarizes and critically reviews the important aspects of the position paper.

Authors with CRIS profile

Susanne Achenbach Department of Transfusion Medicine and Haemostaseology

Involved external institutions

Universität zu Köln DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Heinrich-Heine-Universität Düsseldorf DE Germany (DE) Evangelisches Klinikum Bethel DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) DE Germany (DE)

How to cite

APA:

Pfister, R., Achenbach, S., Boenner, F., Mueller, O.J., Hallek, M., Kochanek, M.,... Kelm, M. (2018). Kommentar zum 2016 Positionspapier der Europäischen Gesellschaft für Kardiologie (ESC) zu kardiovaskulären Komplikationen onkologischer Therapien. Der Kardiologe, 12(1), 19-25. https://doi.org/10.1007/s12181-017-0209-2

MLA:

Pfister, R., et al. "Kommentar zum 2016 Positionspapier der Europäischen Gesellschaft für Kardiologie (ESC) zu kardiovaskulären Komplikationen onkologischer Therapien." Der Kardiologe 12.1 (2018): 19-25.

BibTeX: Download